SX-682

Near Add Your Location

Accepting patients

SX-682

A Phase 1, Open-Label, Dose-Escalation With Expansion Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
Learn more
  • CXCR1 Inhibitor
  • CXCR2 Inhibitor
  • Phase 1
  • Has results